Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells

BACKGROUND: Advanced glycation products (AGEs), as endogenous inflammatory mediator, compromise the physiological function of mesenchymal stem cells (MSCs). MSCs have a potential role in cell replacement therapy in acute myocardial infarction and ischemic cardiomyopathy. However, mechanisms of AGEs...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ke, Wang, Xiao Qun, He, Yu Song, Lu, Lin, Chen, Qiu Jing, Liu, Jing, Shen, Wei Feng
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987998/
https://www.ncbi.nlm.nih.gov/pubmed/20969783
http://dx.doi.org/10.1186/1475-2840-9-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987998/
https://www.ncbi.nlm.nih.gov/pubmed/20969783
http://dx.doi.org/10.1186/1475-2840-9-66

Ejemplares similares